Douglas Hanahan

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Vascular Endothelial Growth Factor

Inflammatory Response

Binding Protein

Top Venues

Science (New York, N.Y.)

Science translational medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Michele De Palma, Douglas Hanahan
Milestones in tumor vascularization and its therapeutic targeting. Nature cancer 5 (6) (2024)
Michele De Palma, Douglas Hanahan
Milestones in tumor vascularization and its therapeutic targeting. Nature cancer (2024)
Michele De Palma, Douglas Hanahan
Milestones in tumor vascularization and its therapeutic targeting. Nature cancer 5 (6) (2024)
Giovanni Ciriello, Luca Magnani, Sarah J Aitken, Leila Akkari, Sam Behjati, Douglas Hanahan, Dan A Landau, Núria López-Bigas, Darío G Lupiáñez, Jean-Christophe Marine, Ana Martin-Villalba, Gioacchino Natoli, Anna C Obenauf, Elisa Oricchio, Paola Scaffidi, Andrea Sottoriva, Alexander Swarbrick, Giovanni Tonon, Sakari Vanharanta, Johannes Zuber
Cancer Evolution: A Multifaceted Affair. Cancer discovery (2023)
Qiqun Zeng, Sadegh Saghafinia, Agnieszka Chryplewicz, Nadine Zangger, Lucine Christe, Yu-Qing Xie, Jeremy Guillot, Simge Yucel, Pumin Li, José A Galván, Eva Karamitopoulou, Inti Zlobec, Dalya Ataca, Fleuriane Gallean, Peng Zhang, José Antonio Rodriguez-Calero, Mark Rubin, Melanie Tichet, Krisztian Homicsko, Douglas Hanahan
Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science (New York, N.Y.) 378 (6621) (2022)
Manuel Fankhauser, Maria A S Broggi, Lambert Potin, Natacha Bordry, Laura Jeanbart, Amanda W Lund, Elodie Da Costa, Sylvie Hauert, Marcela Rincon-Restrepo, Christopher Tremblay, Elena M Cabello, Krisztian Homicsko, Olivier Michielin, Douglas Hanahan, Daniel E Speiser, Melody A Swartz
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. Science translational medicine 9 (407) (2018)